{"id":16972,"date":"2023-01-26T00:00:00","date_gmt":"2023-01-26T00:00:00","guid":{"rendered":"https:\/\/cadca1stg.wpengine.com\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/"},"modified":"2023-05-01T14:36:14","modified_gmt":"2023-05-01T14:36:14","slug":"practical-theorist-13-fentanyl-why-fentanyl-why-now","status":"publish","type":"resource","link":"https:\/\/www.cadca.org\/es\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/","title":{"rendered":"Te\u00f3rico pr\u00e1ctico 13: Fentanilo: por qu\u00e9 fentanilo\/por qu\u00e9 ahora"},"content":{"rendered":"<p class=\"rtecenter\" style=\"box-sizing: border-box; color: rgba(46, 52, 76, 0.8); font-size: 16px; font-variant-numeric: normal; font-variant-east-asian: normal; line-height: 1.7em; margin: 1.12em 0px; padding-right: 10px;\"><a href=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/cadca_pt_fentanyl_v6.pdf\"><strong style=\"box-sizing: border-box;\"><span style=\"box-sizing: border-box; font-size: 22px;\"><span style=\"box-sizing: border-box; font-family: tahoma, geneva, sans-serif;\">Te\u00f3rico pr\u00e1ctico 13: Fentanilo: por qu\u00e9 fentanilo\/por qu\u00e9 ahora<\/span><\/span><\/strong><\/a><br \/>\n\u00a0<\/p>\n<p class=\"rtecenter\">\n<iframe loading=\"lazy\" frameborder=\"0\" height=\"315\" scrolling=\"no\" src=\"https:\/\/www.youtube.com\/embed\/ZcFtq7XJWLA\" width=\"560\"><\/iframe><\/p>\n<p class=\"rtecenter\">\n<strong style=\"color: rgb(0, 0, 0); font-family: tahoma, geneva, sans-serif; font-size: 16px; font-variant-ligatures: none; white-space: pre-wrap;\">Dr. Albert Terrellion<\/strong><span style=\"color: rgb(0, 0, 0); font-family: tahoma, geneva, sans-serif; font-size: 16px; font-variant-ligatures: none; white-space: pre-wrap;\"> (CADA), <\/span><strong style=\"color: rgb(0, 0, 0); font-family: tahoma, geneva, sans-serif; font-size: 16px; font-variant-ligatures: none; white-space: pre-wrap;\">Dr. Subvenci\u00f3n Baldwin<\/strong><span style=\"color: rgb(0, 0, 0); font-family: tahoma, geneva, sans-serif; font-size: 16px; font-variant-ligatures: none; white-space: pre-wrap;\"> (CDC), y\u00a0<\/span><strong style=\"color: rgb(0, 0, 0); font-family: tahoma, geneva, sans-serif; font-size: 16px; font-variant-ligatures: none; white-space: pre-wrap;\">Sra. Merilee Fowler<\/strong><span style=\"color: rgb(0, 0, 0); font-family: tahoma, geneva, sans-serif; font-size: 16px; font-variant-ligatures: none; white-space: pre-wrap;\"> (MATFORCE y Community Counts) proporcion\u00f3 una descripci\u00f3n general del fentanilo, fentanilo farmac\u00e9utico y de fabricaci\u00f3n il\u00edcita (IMF), y por qu\u00e9 es una de las sustancias m\u00e1s peligrosas que circulan en el pa\u00eds. Los presentadores se enfocaron en sus efectos en las poblaciones vulnerables, particularmente en los j\u00f3venes, y discutieron formas de implementar diferentes estrategias (es decir, las Siete Estrategias para el Cambio Comunitario de CADCA) para mejorar a\u00fan m\u00e1s los esfuerzos de prevenci\u00f3n.<\/span><\/p>\n<p>\u00a0<\/p>\n<div style=\"box-sizing: border-box; color: rgba(46, 52, 76, 0.8); font-size: 16px; font-variant-numeric: normal; font-variant-east-asian: normal; text-align: center;\">\n<div style=\"text-align:center\">\n<figure class=\"image\" style=\"display:inline-block\"><a href=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/cadca_pt_fentanyl_v6-1.pdf\"><img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"518\" src=\"https:\/\/cadca.org\/sites\/default\/files\/ptfentanyl.png\" width=\"400\" \/><\/a><\/p>\n<p><figcaption><a href=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/cadca_pt_fentanyl_v6.pdf\">Descargar ahora<\/a><\/figcaption><\/p>\n<\/figure>\n<\/div>\n<p class=\"rteleft\"><span style=\"box-sizing: border-box;\"><span style=\"box-sizing: border-box; font-family: tahoma, geneva, sans-serif;\">El fentanilo es una de las sustancias m\u00e1s peligrosas que circulan en las comunidades de todo Estados Unidos. Es un opioide sint\u00e9tico que es hasta 50 veces m\u00e1s fuerte que la hero\u00edna y 100 veces m\u00e1s fuerte que la morfina (DEA Fentanyl Factsheet, 2020). Tan solo 2 mg de fentanilo, el equivalente a unos pocos granos de sal, puede ser letal, especialmente para j\u00f3venes, adultos j\u00f3venes u otras personas que no hayan usado previamente fentanilo u otros opioides (EMCDDA, 2011).<\/span><\/span><\/p>\n<p class=\"rteleft\"><span style=\"box-sizing: border-box;\"><span style=\"box-sizing: border-box; font-family: tahoma, geneva, sans-serif;\">En 2013 comenzaron aumentos significativos en las muertes por sobredosis de opioides sint\u00e9ticos, en particular fentanilo fabricado il\u00edcitamente (Gladden, Martinez &amp; Seth, 2016; O\u02bcDonnell, Gladden &amp; Seth, 2016; O\u02bcDonnell, Halpin, Mattson, Goldberger &amp; Gladden; 2017). De 2013 a 2019, la tasa de mortalidad por fentanilo y otros opioides sint\u00e9ticos aument\u00f3 de 1,0 a 11,4 por cada 100 000 personas, un aumento de 1040% (Mattson, CL, Tanz, LJ, Quinn, K., et. al., 2021). Y desde 2020, los datos provisionales del Sistema Nacional de Estad\u00edsticas Vitales han seguido documentando una tendencia creciente de muertes por sobredosis (Ahmad, 2022), impulsada en gran medida por los opioides sint\u00e9ticos, como el fentanilo. Se estima que para 2029, m\u00e1s de 1,2 millones de personas morir\u00e1n a causa del fentanilo y otros opioides si no se toman medidas (Rao, IJ., Humphreys K., Brandeau ML., 2021).<\/span><\/span><\/p>\n<p class=\"rteleft\"><span style=\"box-sizing: border-box;\"><span style=\"box-sizing: border-box; font-family: tahoma, geneva, sans-serif;\">Las tendencias recientes en las muertes por sobredosis entre los j\u00f3venes que involucran fentanilo, as\u00ed como las historias individuales de tragedia, est\u00e1n llamando m\u00e1s la atenci\u00f3n sobre este problema para los j\u00f3venes (Ahmad, 2022; Hoffman J., 2022). Hay una serie de razones por las que los j\u00f3venes est\u00e1n en riesgo, incluido, entre otros, un mercado donde los medicamentos que contienen fentanilo est\u00e1n m\u00e1s disponibles y accesibles, incluso en p\u00edldoras falsificadas com\u00fanmente disponibles para j\u00f3venes y adultos j\u00f3venes a trav\u00e9s de las plataformas de redes sociales (Comunicado de prensa de la DEA, 2021); la falta de exposici\u00f3n previa a los opioides, lo que hace que las drogas con incluso peque\u00f1as cantidades de fentanilo tengan m\u00e1s probabilidades de ser letales; falta de conocimiento sobre el fentanilo y su presencia en otras sustancias (Fentanylawarenessday.org, 2022); y la mayor necesidad de abordar la conexi\u00f3n, la resiliencia y otros factores de protecci\u00f3n de los j\u00f3venes, dados los impactos negativos de la pandemia de COVID-19 en la salud mental de los j\u00f3venes (Jones SE., 2022). Estos factores hacen que la necesidad de esfuerzos de prevenci\u00f3n primaria sea m\u00e1s importante que nunca.<\/span><\/span><\/p>\n<p class=\"rteleft\"><span style=\"box-sizing: border-box;\"><span style=\"box-sizing: border-box; font-family: tahoma, geneva, sans-serif;\">Dada la urgencia y la magnitud de la crisis de los opioides, que actualmente est\u00e1 siendo impulsada por el aumento en la disponibilidad de fentanilo fabricado il\u00edcitamente, altamente letal, es fundamental centrarse en la prevenci\u00f3n primaria y estar informado sobre otros trabajos para salvar vidas. Centrarse en las estrategias de prevenci\u00f3n primaria, como aumentar la conciencia y promover los factores de protecci\u00f3n en las escuelas y las comunidades, puede ayudar a mejorar las estrategias m\u00e1s amplias que se utilizan para revertir los aumentos en las muertes por sobredosis, como las asociaciones de colaboraci\u00f3n con la salud p\u00fablica y la seguridad p\u00fablica; pr\u00e1cticas seguras de prescripci\u00f3n; acceso a programas de recuperaci\u00f3n y tratamiento por uso de sustancias; y promoci\u00f3n de servicios como distribuci\u00f3n de naloxona, tiras reactivas de fentanilo y programas de servicios de jeringas.<\/span><\/span><\/p>\n<p class=\"rtecenter\" style=\"box-sizing: border-box; line-height: 1.7em; margin: 1.12em 0px; padding-right: 10px;\">\u00a0<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now \u00a0 Dr. Albert Terrillion (CADCA), Dr. Grant Baldwin (CDC), and\u00a0Ms. Merilee Fowler (MATFORCE<\/p>","protected":false},"author":23,"featured_media":16973,"template":"","resource_type":[290],"drug_specific_issues":[311,295],"action_to_do":[],"class_list":["post-16972","resource","type-resource","status-publish","has-post-thumbnail","hentry","resource_type-practical-theorist","drug_specific_issues-emerging-drug-trends","drug_specific_issues-synthetic-drugs"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now | CADCA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cadca.org\/es\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now | CADCA\" \/>\n<meta property=\"og:description\" content=\"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now \u00a0 Dr. Albert Terrillion (CADCA), Dr. Grant Baldwin (CDC), and\u00a0Ms. Merilee Fowler (MATFORCE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cadca.org\/es\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/\" \/>\n<meta property=\"og:site_name\" content=\"CADCA\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-01T14:36:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png\" \/>\n\t<meta property=\"og:image:width\" content=\"621\" \/>\n\t<meta property=\"og:image:height\" content=\"808\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/\",\"url\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/\",\"name\":\"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now | CADCA\",\"isPartOf\":{\"@id\":\"https:\/\/www.cadca.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png\",\"datePublished\":\"2023-01-26T00:00:00+00:00\",\"dateModified\":\"2023-05-01T14:36:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#primaryimage\",\"url\":\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png\",\"contentUrl\":\"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png\",\"width\":621,\"height\":808},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cadca.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cadca.org\/#website\",\"url\":\"https:\/\/www.cadca.org\/\",\"name\":\"CADCA\",\"description\":\"The Premier Prevention Association\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cadca.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now | CADCA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cadca.org\/es\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/","og_locale":"es_ES","og_type":"article","og_title":"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now | CADCA","og_description":"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now \u00a0 Dr. Albert Terrillion (CADCA), Dr. Grant Baldwin (CDC), and\u00a0Ms. Merilee Fowler (MATFORCE","og_url":"https:\/\/www.cadca.org\/es\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/","og_site_name":"CADCA","article_modified_time":"2023-05-01T14:36:14+00:00","og_image":[{"width":621,"height":808,"url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/","url":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/","name":"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now | CADCA","isPartOf":{"@id":"https:\/\/www.cadca.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#primaryimage"},"image":{"@id":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png","datePublished":"2023-01-26T00:00:00+00:00","dateModified":"2023-05-01T14:36:14+00:00","breadcrumb":{"@id":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#primaryimage","url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png","contentUrl":"https:\/\/www.cadca.org\/wp-content\/uploads\/2023\/05\/ptfentanyl.png","width":621,"height":808},{"@type":"BreadcrumbList","@id":"https:\/\/www.cadca.org\/resource\/practical-theorist-13-fentanyl-why-fentanyl-why-now\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cadca.org\/"},{"@type":"ListItem","position":2,"name":"Practical Theorist 13: Fentanyl: Why Fentanyl\/Why Now"}]},{"@type":"WebSite","@id":"https:\/\/www.cadca.org\/#website","url":"https:\/\/www.cadca.org\/","name":"CADCA","description":"The Premier Prevention Association","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cadca.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/resource\/16972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/types\/resource"}],"author":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/users\/23"}],"version-history":[{"count":0,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/resource\/16972\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/media\/16973"}],"wp:attachment":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/media?parent=16972"}],"wp:term":[{"taxonomy":"resource_type","embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/resource_type?post=16972"},{"taxonomy":"drug_specific_issues","embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/drug_specific_issues?post=16972"},{"taxonomy":"action_to_do","embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/action_to_do?post=16972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}